Literature DB >> 3777037

Variability in potassium removal by hemodialysis.

R A Sherman, E R Hwang, A S Bernholc, R P Eisinger.   

Abstract

The extent to which plasma potassium determines potassium removal in hemodialysis was examined in 8 end-stage renal disease patients during 51 treatments. Dialyzers, treatment time, blood and dialysate flow were held constant. Dialysate composition was also uniform except that 24 treatments utilized glucose-free dialysate and the remaining 27 a 200 mg/dl glucose bath. At either level of dialysate glucose, approximately 40% of the potassium removal during dialysis could not be accounted for by plasma-dialysate potassium gradient, body weight or serum carbon dioxide content, although glucose-free dialysate tended to increase potassium removal by a mean of 28%. The large, unexplained variability in potassium removal suggests that therapeutic manipulation of potassium flux across cell membranes may improve the management of potassium balance in hemodialyzed patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777037     DOI: 10.1159/000167176

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  7 in total

Review 1.  Pathogenesis and treatment of dyskalemia in maintenance hemodialysis and CAPD.

Authors:  Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2006-03

Review 2.  Hyperkalemia revisited.

Authors:  Walter A Parham; Ali A Mehdirad; Kurt M Biermann; Carey S Fredman
Journal:  Tex Heart Inst J       Date:  2006

Review 3.  Dialysate potassium concentration: Should mass balance trump electrophysiology?

Authors:  Patrick H Pun
Journal:  Semin Dial       Date:  2018-07-19       Impact factor: 3.455

Review 4.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

5.  Hemodialysis: core curriculum 2014.

Authors:  Thomas A Golper; Rachel Fissell; William H Fissell; P Matthew Hartle; M Lee Sanders; Gerald Schulman
Journal:  Am J Kidney Dis       Date:  2013-11-19       Impact factor: 8.860

Review 6.  Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.

Authors:  Patrick H Pun; John P Middleton
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

7.  Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.

Authors:  Shilpa Vijayakumar; Javed Butler; George L Bakris
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.